OkudaDTMowryEMBeheshtianA, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology2009; 72: 800–805.
2.
AzevedoCJOvertonEKhadkaS, et al. Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm2015; 2(3): e102.
3.
GeorgeICEl MendiliMMIngleseM, et al. Cerebellar volume loss in radiologically isolated syndrome. Mult Scler2019; 27: 130–133.
4.
Lebrun-FrenayCKantarciOSivaA, et al. Radiologically isolated syndrome: 10-year risk estimate of a clinical event. Ann Neurol2020; 88: 407–417.
5.
Lebrun-FrenayCRollotFMondotL, et al. Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome. JAMA Netw Open2021; 4: e2128271.
6.
OkudaDTSivaAKantarciO, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE2014; 9(3): e90509.
7.
De StefanoNGiorgioATintoreM, et al. Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. Mult Scler2018; 24: 214–221.
8.
GoutOLebrun-FrenayCLabaugeP, et al. Prior suggestive symptoms in one-third of patients consulting for a ‘first’ demyelinating event. J Neurol Neurosurg Psychiatry2011; 82(3): 323–325.
9.
OkudaDTKantarciOLebrun-FrénayC, et al. Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome. Ann Neurol2023; 93(3): 604–614. DOI: 10.1002/ana.26555.
10.
Lebrun-FrenayCLandes-ChâteauCSivaA, et al; on behalf of RISC and SFSEP. Multi-center, randomized, double-blinded assessment of TERIFLUNOMIDE (Aubagio®) in extending the time to the first attack in radiologically isolated syndrome: Baseline characteristics of the TERIS study. (P5-4.011). Neurology2022; 98(Suppl. 18): 1116.
